In one paragraphArticle in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Manoj K DoodaDepartment of Biological Sciences, University of North Carolina at Charlotte, Charlotte, North Carolina, USA.
Anna PotapovaDepartment of Microbiology and Environmental Toxicology, University of California Santa Cruz, Santa Cruz, California, USA.
Sofia PiepoliDepartment of Microbiology and Environmental Toxicology, University of California Santa Cruz, Santa Cruz, California, USA.
Evgeny VinogradovNational Research Council, Ottawa, Ontario, Canada.
Fitnat H YildizDepartment of Microbiology and Environmental Toxicology, University of California Santa Cruz, Santa Cruz, California, USA.ORCID 0000-0002-6384-7167 Jerry M TroutmanDepartment of Chemistry, University of North Carolina at Charlotte, Charlotte, North Carolina, USA.ORCID 0000-0002-8340-462X Funding
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2MVibrio cholerae biofilms: structure, function, regulation and role in infectionR01AI114261 · NIAID · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI YILDIZ, HAVVA FITNAT · 2014 to 2024
$5.0MIn vitro and Cellular Tools for Complex Polysaccharide BiosynthesisR01GM123251 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI TROUTMAN, JERRY M · 2017 to 2023
$2.1MVibrio cholerae c-diGMP signaling: Motile to biofilm transition and transmissionR37AI102584 · NIAID · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Havva Fitnat Yildiz · 2025 to 2026
$1.5MNational Institue of Allergy and Infectious Diseases R37AI102584National Institute of Allergy and Infectious Diseases R01AI114261NIAID NIH HHS R01 AI114261NIAID NIH HHS R37 AI102584NIGMS NIH HHS R01 GM123251NIGMS NIH HHS R01GM123251NIGMS NIH HHS R01 GM129325
6 · The paper itselfAbstract
Biofilm formation underlies the environmental persistence and transmission of
Indexed as
BiofilmsPolysaccharides, BacterialVibrio choleraeBacterial ProteinsBiosynthetic PathwaysGene DeletionBacterial ProteinsPolysaccharides, BacterialbiofilmsexopolysaccharideglycanglycosyltransferaseVibrio choleraeVibrio polysaccharide
Identifiers
PMID42446211
PMCPMC13463779
What OpenQuestion holds
Textmetadata
Read underepoch 390